Journal article · 2013
P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials
European Neuropsychopharmacology, 23, S485 · Published 21 September 2013 · DOI 10.1016/s0924-977x(13)70768-5
In brief
“P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials” is a 2013 journal article by Christoph Ulrich Correll and 5 co-authors, published in European Neuropsychopharmacology. OpenAlex counts 2 citations as of 20 November 2026, which puts it in the top 7% of works published in 2013 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 2
- Most cited in
- 2015 (2)
- Field-weighted impact
- 0.35
- Authors
- 6
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Correll, C. U., Werner, P., Pikalov, A., Hsu, J., Cucchiaro, J. B., & Loebel, A. D. (2013). P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials. European Neuropsychopharmacology, 23, S485. https://doi.org/10.1016/s0924-977x(13)70768-5
MLA 9
Correll, Christoph Ulrich, et al. “P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials.” European Neuropsychopharmacology, vol. 23, 2013, p. S485. https://doi.org/10.1016/s0924-977x(13)70768-5.
Chicago
Correll, Christoph Ulrich, P. Werner, Andrei Pikalov, Jay Hsu, Josephine B. Cucchiaro, and Antony D Loebel. 2013. “P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials.” European Neuropsychopharmacology 23: S485. https://doi.org/10.1016/s0924-977x(13)70768-5.
Harvard
Correll, C. U. et al. (2013) ‘P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials’, European Neuropsychopharmacology, 23, p. S485. doi:10.1016/s0924-977x(13)70768-5.
IEEE
C. U. Correll, P. Werner, A. Pikalov, J. Hsu, J. B. Cucchiaro, and A. D. Loebel, “P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials,” European Neuropsychopharmacology, vol. 23, p. S485, 2013, doi: 10.1016/s0924-977x(13)70768-5.
BibTeX
@article{correll2013early,
title = {{P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials}},
author = {Correll, Christoph Ulrich and Werner, P. and Pikalov, Andrei and Hsu, Jay and Cucchiaro, Josephine B. and Loebel, Antony D},
journal = {European Neuropsychopharmacology},
year = {2013},
volume = {23},
pages = {S485},
doi = {10.1016/s0924-977x(13)70768-5},
url = {https://doi.org/10.1016/s0924-977x(13)70768-5}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- lurasidone
- schizophrenia
- early treatment response
- atypical antipsychotics
- pooled analysis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Correll, C. U., Werner, P., Pikalov, A., Hsu, J., Cucchiaro, J. B., & Loebel, A. D. (2013). P.3.d.045 Early improvement predicts endpoint response to lurasidone in schizophrenia: pooled analysis of five double-blind trials. European Neuropsychopharmacology, 23, S485. https://doi.org/10.1016/s0924-977x(13)70768-5
How many times has this paper been cited?
2 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Christoph Ulrich Correll, P. Werner, Andrei Pikalov, Jay Hsu, Josephine B. Cucchiaro, Antony D Loebel.
What is the DOI of this paper?
10.1016/s0924-977x(13)70768-5, permanently at https://doi.org/10.1016/s0924-977x(13)70768-5. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.